Literature DB >> 23673224

Predicting CYP2C19 catalytic parameters for enantioselective oxidations using artificial neural networks and a chirality code.

Jessica H Hartman1, Steven D Cothren, Sun-Ha Park, Chul-Ho Yun, Jerry A Darsey, Grover P Miller.   

Abstract

Cytochromes P450 (CYP for isoforms) play a central role in biological processes especially metabolism of chiral molecules; thus, development of computational methods to predict parameters for chiral reactions is important for advancing this field. In this study, we identified the most optimal artificial neural networks using conformation-independent chirality codes to predict CYP2C19 catalytic parameters for enantioselective reactions. Optimization of the neural networks required identifying the most suitable representation of structure among a diverse array of training substrates, normalizing distribution of the corresponding catalytic parameters (k(cat), K(m), and k(cat)/K(m)), and determining the best topology for networks to make predictions. Among different structural descriptors, the use of partial atomic charges according to the CHelpG scheme and inclusion of hydrogens yielded the most optimal artificial neural networks. Their training also required resolution of poorly distributed output catalytic parameters using a Box-Cox transformation. End point leave-one-out cross correlations of the best neural networks revealed that predictions for individual catalytic parameters (k(cat) and K(m)) were more consistent with experimental values than those for catalytic efficiency (k(cat)/K(m)). Lastly, neural networks predicted correctly enantioselectivity and comparable catalytic parameters measured in this study for previously uncharacterized CYP2C19 substrates, R- and S-propranolol. Taken together, these seminal computational studies for CYP2C19 are the first to predict all catalytic parameters for enantioselective reactions using artificial neural networks and thus provide a foundation for expanding the prediction of cytochrome P450 reactions to chiral drugs, pollutants, and other biologically active compounds.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23673224      PMCID: PMC3674096          DOI: 10.1016/j.bmc.2013.04.044

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  50 in total

1.  Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes.

Authors:  O V Olesen; K Linnet
Journal:  Pharmacology       Date:  1999-12       Impact factor: 2.547

2.  New description of molecular chirality and its application to the prediction of the preferred enantiomer in stereoselective reactions.

Authors:  J Aires-de-Sousa; J Gasteiger
Journal:  J Chem Inf Comput Sci       Date:  2001 Mar-Apr

Review 3.  Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles.

Authors:  D F Lewis
Journal:  Toxicology       Date:  2000-04-03       Impact factor: 4.221

4.  A neural network based virtual screening of cytochrome P450 3A4 inhibitors.

Authors:  László Molnar; György M Keseru
Journal:  Bioorg Med Chem Lett       Date:  2002-02-11       Impact factor: 2.823

5.  Prediction of enantiomeric selectivity in chromatography. Application of conformation-dependent and conformation-independent descriptors of molecular chirality.

Authors:  João Aires-de-Sousa; Johann Gasteiger
Journal:  J Mol Graph Model       Date:  2002-03       Impact factor: 2.518

Review 6.  Predictive non-linear modeling of complex data by artificial neural networks.

Authors:  Jonas S Almeida
Journal:  Curr Opin Biotechnol       Date:  2002-02       Impact factor: 9.740

7.  Stereoselective metabolism of bufuralol racemate and enantiomers in human liver microsomes.

Authors:  Shizuo Narimatsu; Chie Takemi; Daisuke Tsuzuki; Hiroyuki Kataoka; Shigeo Yamamoto; Noriaki Shimada; Satoshi Suzuki; Tetsuo Satoh; Urs A Meyer; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

8.  (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes.

Authors:  J M Margolis; J P O'Donnell; D C Mankowski; S Ekins; R S Obach
Journal:  Drug Metab Dispos       Date:  2000-10       Impact factor: 3.922

9.  A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.

Authors:  S Rao; R Aoyama; M Schrag; W F Trager; A Rettie; J P Jones
Journal:  J Med Chem       Date:  2000-07-27       Impact factor: 7.446

10.  Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes.

Authors:  Mitsuo Miyazawa; Masaki Shindo; Tsutomu Shimada
Journal:  Drug Metab Dispos       Date:  2002-05       Impact factor: 3.922

View more
  4 in total

1.  Learning epistatic interactions from sequence-activity data to predict enantioselectivity.

Authors:  Julian Zaugg; Yosephine Gumulya; Alpeshkumar K Malde; Mikael Bodén
Journal:  J Comput Aided Mol Des       Date:  2017-12-12       Impact factor: 3.686

2.  Improving quantitative structure-activity relationship models using Artificial Neural Networks trained with dropout.

Authors:  Jeffrey Mendenhall; Jens Meiler
Journal:  J Comput Aided Mol Des       Date:  2016-02-01       Impact factor: 3.686

3.  Modeling, optimization and experimental studies of supported nano-bimetallic catalyst for simultaneous total conversion of toluene and cyclohexane in air using a hybrid intelligent algorithm.

Authors:  Mohammad Zabihi; Nasser Babajani
Journal:  RSC Adv       Date:  2018-05-14       Impact factor: 3.361

4.  Learning a Local-Variable Model of Aromatic and Conjugated Systems.

Authors:  Matthew K Matlock; Na Le Dang; S Joshua Swamidass
Journal:  ACS Cent Sci       Date:  2018-01-03       Impact factor: 14.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.